ASTRAZENECA PLC

(AZN)
  Rapport
Vertraagde tijd London Stock Exchange  -  17:35 30-06-2022
10794.00 GBX   -2.35%
12:59AstraZeneca zegt dat de tussentijdse gegevens van de fase 3-studie aantonen dat Imfinzi plus chemotherapie de pathologische respons bij longkankerpatiënten verbetert
MT
09:49S.Korea geeft AstraZeneca toestemming voor COVID-therapie Evusheld voor kwetsbare personen
MR
09:47AstraZeneca zegt dat Imfinzi combo veelbelovend is in laat stadium longkankerproef
MR
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
OfficiŽle publicaties
30/04/22Monthly statement on outstanding equity shares and voting rights 
29/04/221st quarter results 
29/04/22Proxy Statments 
28/02/22Monthly statement on outstanding equity shares and voting rights 
22/02/22Annual Report 
10/02/22Dividends 
10/02/22Annual results 
31/01/22Monthly statement on outstanding equity shares and voting rights 
31/12/21Monthly statement on outstanding equity shares and voting rights 
30/11/21Monthly statement on outstanding equity shares and voting rights 
12/11/21Press Release 
12/11/213rd quarter results 
31/10/21Monthly statement on outstanding equity shares and voting rights 
30/09/21Monthly statement on outstanding equity shares and voting rights 
31/08/21Monthly statement on outstanding equity shares and voting rights 
31/07/21Monthly statement on outstanding equity shares and voting rights 
29/07/21Press Release 
29/07/21Half-year results 
30/06/21Monthly statement on outstanding equity shares and voting rights 
31/05/21Monthly statement on outstanding equity shares and voting rights 
17/05/21Acquisition 
11/05/21Proxy Statments 
30/04/21Press Release 
30/04/211st quarter results 
11/02/21Press Release 
11/02/21Annual results 
31/01/21Monthly statement on outstanding equity shares and voting rights 
31/12/20Institutional report 
31/12/20Annual Report 
31/12/20Monthly statement on outstanding equity shares and voting rights 
30/11/20Monthly statement on outstanding equity shares and voting rights 
05/11/203rd quarter results 
31/10/20Monthly statement on outstanding equity shares and voting rights 
30/09/20Monthly statement on outstanding equity shares and voting rights 
25/09/20Nomination 
31/08/20Monthly statement on outstanding equity shares and voting rights 
07/08/20Crossing thresholds 
31/07/20Monthly statement on outstanding equity shares and voting rights 
30/07/20Press Release 
21/07/20Crossing thresholds 
16/07/20Nomination 
30/06/20Monthly statement on outstanding equity shares and voting rights 
30/06/20Half-year report 
31/05/20Monthly statement on outstanding equity shares and voting rights 
30/04/20Monthly statement on outstanding equity shares and voting rights 
29/04/20Press Release 
29/04/201st quarter results 
31/03/20Monthly statement on outstanding equity shares and voting rights 
28/02/20Monthly statement on outstanding equity shares and voting rights 
31/01/20Monthly statement on outstanding equity shares and voting rights 
Volgende evenement op ASTRAZENECA PLC